A pilot study to investigate the efficacy of low-dose botulinum toxin type A in the treatment of spastic dropped foot in stroke patients

被引:0
|
作者
de Moura Ramos, A [1 ]
Barbosa, MCC [1 ]
Chung, TM [1 ]
dos Santos Moreira, MC [1 ]
Battistella, LR [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Hosp Clin, Div Rehabil Med, BR-05508 Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Botulinum toxin type A (BTA) in combination with Physical Therapy (PT) may improve Spastic Dropped Foot (SPF), one disabling condition often encountered in stroke patients. However, the doses prescribed have varied a lot in the literature. We studied retrospectively 11 stroke patients (6 women, 5 men) who were given low-dose BTA into gastrosoleus/tibialis posterior muscles (50 U into every point) to treat spasticity. Muscle tone, ankle goniometry and FIM motor index were assessed pre and post-treatment as well as subjective improvement by the examiner. There was some improvement in the mus:Je tone, but there was no significant improvement regarding the other features. All patients had a subjective improvement. According to our preliminary data, low-dose BTA seemed to be little effective in improving SDF.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 50 条
  • [11] Low-dose botulinum toxin in the treatment of cervical dystonia
    Gogovska, L
    Ljapcev, R
    NEUROLOGY, 1997, 48 (03) : 2078 - 2078
  • [12] A SINGLE-BLINDED, RANDOMIZED PILOT STUDY OF BOTULINUM TOXIN TYPE A COMBINED WITH NON-PHARMACOLOGICAL TREATMENT FOR SPASTIC FOOT
    Baricich, Alessio
    Carda, Stefano
    Bertoni, Michele
    Maderna, Luca
    Cisari, Carlo
    JOURNAL OF REHABILITATION MEDICINE, 2008, 40 (10) : 870 - 872
  • [13] Baropodometric analysis of stance in stroke patients treated with botulinum toxin for spastic equinovarus foot
    Abbruzzese, G
    Lentino, C
    Diociaiuti, S
    Baldi, F
    Marchese, R
    Trompetto, C
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R9 - R9
  • [14] A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot
    F. Mancini
    G. Sandrini
    A. Moglia
    G. Nappi
    C. Pacchetti
    Neurological Sciences, 2005, 26 : 26 - 31
  • [15] A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot
    Mancini, F
    Sandrini, G
    Moglia, A
    Nappi, G
    Pacchetti, C
    NEUROLOGICAL SCIENCES, 2005, 26 (01) : 26 - 31
  • [16] Low-dose botulinum toxin-A treatment of cervical dystonia - A double-blind, randomized pilot study
    Laubis-Herrmann, U
    Fries, K
    Topka, H
    EUROPEAN NEUROLOGY, 2002, 47 (04) : 214 - 221
  • [17] Low-dose botulinum toxin A for treatment of blepharospasm and hemifacial spasm
    Poonyathalang A.
    Preechawat P.
    Jamnansiri U.
    Japanese Journal of Ophthalmology, 2005, 49 (4) : 327 - 328
  • [18] Low-dose botulinum toxin A for treatment of blepharospasm and hemifacial spasm
    Poonyathalang, A
    Preechawat, P
    Jamnansiri, U
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2005, 49 (04) : 327 - 328
  • [19] Botulinum toxin B treatment in children with spastic movement disorders: A pilot study
    Schwerin, A
    Berweck, S
    Fietzek, UM
    Heinen, F
    PEDIATRIC NEUROLOGY, 2004, 31 (02) : 109 - 113
  • [20] Botulinum toxin type-A treatment in spastic paraparesis: a neurophysiological study
    Pauri, F
    Boffa, L
    Cassetta, E
    Pasqualetti, P
    Rossini, PM
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 181 (1-2) : 89 - 97